Join to View Full Profile
630 W 168th StCUMC New York Presbyterian HospitalNew York, NY 10032
Phone+1 212-305-2913
Dr. Akala is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2014 - 2017
New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 2011 - 2014
University of Michigan Medical SchoolClass of 2011
Certifications & Licensure
NY State Medical License 2014 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Pembrolizumab 400 mg every 6 weeks as first-line therapy for advanced melanoma (KEYNOTE-555): Results from cohort B of an open-label, phase 1 study.Graham Cohen, Bernardo Rapoport, Sze W Chan, Paul Ruff, Ana Arance
Plos One. 2024-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
